News
-
-
-
PRESS RELEASE
POP Biotechnologies Announces Phase 3 Trial Interim Results Published for COVID-19 Vaccine Based on POP BIO SNAP(TM)
POP Biotechnologies and EuBiologics announce positive findings of ECV-19 COVID-19 vaccine in Phase 3 trial in the Philippines, demonstrating safety, immunogenicity, and potential against Omicron variant -